Mendus AB

Immunicum is leveraging its unparalleled expertise in dendritic cell biology to develop novel, off-the-shelf, cell-based therapies for solid and blood-borne tumors. With complementary therapeutic approaches in Phase II clinical development that are based on intratumoral priming and cancer relapse vaccination, the company aims to improve survival outcomes and quality of life for a broad population of cancer patients. Based in Sweden and the Netherlands, Immunicum is publicly traded on the Nasdaq Stockholm.

Website: http://www.mendus.com

Employees: 37

HQ: +46 (0)8 732 8400

Location: Stockholm, Stockholm County, Sweden

Revenue:

Mendus AB Technologies

Email Providers

Outlook

Load Balancers

Varnish

Other

Mobile Friendly

View All Technologies Used At Mendus AB

Similar companies to Mendus AB

HYBRIT Moligo Technologies BioReperia Aventure AB Melt&Marble World Values Survey Association SAFER Vehicle and Traffic Safety Centre at Chalmers Statisticon Procella Therapeutics AB Stiftelsen Stockholms läns Äldrecentrum Attana Nidacon International AB Agrisera AB Department of Sociology, Stockholm University Swelife Spago Nanomedical AB Eclipse Optics Faurecia Creo Dynamics Riksbankens Jubileumsfond CR Competence AB

Contacting Mendus AB: Connect with Executives and Employees

Get in Touch with Mendus AB Executives and Employees

Connecting with Mendus AB's Executives and Workforce

Accessing Contact Information for Mendus AB Executives

Connecting with Mendus AB: Reach Out to Their Team

Discover How to Contact Mendus AB Executives and Staff

Looking to connect with Mendus AB executives or employees?

Seeking to Get in Touch with Mendus AB Executives or Staff?

Want to Reach Out to Mendus AB Executives or Team Members?

In Search of Contact Details for Mendus AB Professionals?

Connecting with Mendus AB: Contacting Executives and Staff

Browse companies

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z